Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Introduction to the 3DEXPERIENCE License to Cure and its Applicability in Audit-Ready Medical Device Development, Upcoming Webinar Hosted by Xtalks


The medical device industry requires well-defined solutions for process flow so that companies can be ready when an audit takes place. The 3DEXPERIENCE License to Cure software solution is a new tool for managing process flow. It is designed to accelerate the delivery of safe, innovative and fully compliant medical devices. Different modules are packaged within the software, including those catering to management requirements, traceability and validation. The software can also manage the design history file (DHF), device master record (DMR) and regulatory licenses, all in an automated fashion. It also has a module to track device complaints to the specific product version. Join this webinar to learn more about the License to Cure software package by TECHNIA.

Join featured speakers from TECHNIA, Rehan Chaudry, Sales Executive; and Smita Bhattacharjee, Senior Business Consultant, in a live webinar on Friday, December 11, 2020 at 9am EST (2pm GMT/UK) to learn more about the License to Cure software package.

For more information, or to register for this event, visit Introduction to the 3DEXPERIENCE License to Cure and its Applicability in Audit-Ready Medical Device Development.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

What’s Still Going Wrong? Upcoming Webinar Hosted by Xtalks


Learn more about some of the common and potential points of vulnerability with commercial as well as safety and reputational implications, and what companies can do to reduce those risks.

When the current European pharmacovigilance (PV) legislation came into force in Europe in 2012, pharmaceutical companies targeting the region had to put in place a number of formal measures to monitor the safety of products and any issues once those products were being marketed in the real world.

These measures also mandate that life sciences companies must run, check and document their PV activities so that regulatory authorities can be confident that standards are being upheld and that nothing is being missed.

This means pharmaceutical organizations must be able to provide evidence of strong standard operating procedures on demand, and that includes measures implemented down the supply chain. Yet, even today, companies are still struggling to fulfill their obligations, causing marketing authorization holders (MAHs) to fail inspections, incur fines and see products withdrawn from markets.

Join expert speakers from Arriello, Vanessa Fachada, Pharmacovigilance Manager and EU QPPV; and Peter Kohut, Director of Drug Safety and EU QPPV, in a live webinar on Thursday, December 10, 2020 at 11am EST (4pm GMT/UK) to learn more about some of the common and potential points of vulnerability with commercial as well as safety and reputational implications, and what companies can do to reduce those risks.

For more information, or to register for this event, visit Pharmacovigilance Audit Failures: What’s Still Going Wrong?

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

5 Ways the Human-Animal Bond is Improving Lives During the Pandemic


Human Animal Bond Research Institute

“This is the time of year when many of us reflect on all of the things for which we are thankful. For pet owners, the human-animal bond is high on that list,” said HABRI Executive Director Steven Feldman.

In recognition of how pets are helping us during the pandemic and just in time for the Thanksgiving holiday, the Human Animal Bond Research Institute (HABRI) has created a new shareable infographic, “5 Ways the Human-Animal Bond is Improving Lives During the Pandemic”. The infographic highlights research showing the positive role of pets in providing companionship and relief from stress, anxiety and loneliness.

“This is the time of year when many of us reflect on all of the things for which we are thankful. For pet owners, the human-animal bond is high on that list,” said HABRI Executive Director Steven Feldman. “HABRI’s goal is to raise awareness of the important role of the human-animal bond, especially during difficult times.”

This infographic is part of an ongoing series to share human-animal bond research. In October, HABRI released the “Top 5 Health Benefits of Cat Ownership” infographic. In June, HABRI shared “Can Pets Help You Live Longer?”.

About HABRI

HABRI is a not-for-profit organization that maintains the world’s largest online library of human-animal bond research and information; funds innovative research projects to scientifically document the health benefits of companion animals; and informs the public about human-animal bond research and the beneficial role of companion animals in society. For more information, please visit https://habri.org/.

Share article on social media or email:

Researchers at The Fenway Institute, Brown University Show Association between Negative Media Portrayals of Transgender People and Adverse Mental Health Outcomes


Fenway Health logo

…But those who reported greater frequency of exposure to these messages were significantly more likely to exhibit clinical symptoms of depression, anxiety, global psychological distress, and PTSD.

A new study published in LGBT Health found that frequent exposure to negative depictions of transgender people in the media was significantly associated with clinical symptoms of depression, anxiety, global psychological distress, and post-traumatic stress disorder (PTSD) in this population. The study was authored by researchers at The Fenway Institute and Brown University and is believed to be the first of its kind to explore the effects of exposure to negative transgender-related media across a range of platforms on transgender people. It is an important addition to the extensive body of research showing a correlation between negative media depictions of stigmatized groups and poorer mental health outcomes, as few studies focus solely on transgender people.

“Nearly all of our study participants reported having seen negative depictions of transgender people in media over the past 12 months,” said study lead author Jaclyn White Hughto, PhD, MPH, Assistant Professor, Brown University School of Public Health. “But those who reported greater frequency of exposure to these messages were significantly more likely to exhibit clinical symptoms of depression, anxiety, global psychological distress, and PTSD. The association held even after adjustments were made for variables such as age, race, income, and reported experiences of childhood and/or adult sexual or physical abuse, which suggests that negative media messages may have an independent impact on the mental health of transgender populations exposed to such messages.

The study titled “Negative Transgender-Related Media Messages are Associated with Adverse Mental Health Outcomes in a Multi-State Study of Transgender Adults,” was conducted between March and August 2019 when 545 study participants completed a one-time survey assessing demographics, negative transgender-related media messages, violence, and mental health. Participants were asked to rate how often, on a scale from zero to four, that they saw negative messages about transgender people on television, in print newspapers and magazines, and in advertisements and signs, including billboards, yard signs, bumper stickers, and flyers.

Findings from the study show the following:

  • Nearly all (97.6%) of the study participants reported having seen negative depictions of transgender people in the media in the prior 12 months
  • The percentage of those reporting negative depictions of transgender people in print media (93.9%) and television (93.8%) were nearly identical and 83.1% reported having seen negative depictions of transgender people in advertisements and signs.
  • More frequent exposure to negative media depictions was associated with 18% increased odds of being depressed, 26% increased odds of experiencing anxiety, 25% increased odds of PTSD, and 28% increased odds of experiencing global psychological distress.

“Given the prevalence of systemic discrimination against transgender people in employment, health care settings, schools, and housing, we have long known that structural interventions are required to target stigma at its source,” Hughto added. “Campaigns designed to encourage accurate, non-stigmatizing depictions of transgender people across all media could serve to mitigate the harms of negative media messages to transgender people. In the meantime, clinical interventions can also help transgender people cope with the stress of being exposed to negative transgender-related media.”

Since 1971, Fenway Health has been working to make life healthier for the people in our neighborhoods, the LGBTQIA+ community, people living with HIV/AIDS and the broader population. The Fenway Institute at Fenway Health is an interdisciplinary center for research, training, education and policy development focusing on national and international health issues.

The Brown University School of Public Health is committed to tackling the pressing health challenges of our time and improving population health by advancing science and training tomorrow’s leaders. Our nationally-renown research centers have expertise in key aspects of health and the ability to translate cutting-edge research into high-impact policies and care initiatives. The School’s student-centered academic training and culture of collaboration prepare future health leaders to respond to urgent health challenges. Public Health at Brown goes beyond preventing disease to reshaping health care and safeguarding vulnerable populations. For more information, follow us on Twitter @Brown_SPH

Share article on social media or email:

Nanocan Therapeutics Corporation Announces Funding Round


“Our mission is to never leave cancer patients and their families without hope for improvement and to never let them hear the words ‘there is nothing we can do’,” said Eric Broyles, founder of Nanocan.

Nanocan Therapeutics Corporation, an early stage biotechnology company based in Princeton, New Jersey, announced today that it has closed a $1.4 million funding round. This funding round was led by Nanocan’s Founder and CEO, Eric Broyles, along with LifeForce Capital and Bearcat Investments, LLC. To date, over $7 million in research and development grant funding has been invested in Nanocan’s proprietary cancer treatment technology.

Nanocan is developing cutting-edge technologies that will lead to major advances in cancer treatment. Their nanotechnology-based innovations will focus on therapeutic medicines to treat certain cancers and respiratory diseases where current interventions are insufficient.

“Our mission is to never leave cancer patients and their families without hope for improvement and to never let them hear the words ‘there is nothing we can do’,” said Eric Broyles, founder of Nanocan. “We envision providing treatment modalities in the U.S. and worldwide. Outside of the U.S., Nanocan will focus on underserved and developing countries, starting with markets in Africa.”

Nanocan has partnerships with several leading academic research institutions to develop and commercialize therapies that may ultimately result in optimal standards of care and improvements in the quality of life for cancer patients.

About Nanocan Therapeutics Corporation

Nanocan Therapeutics Corporation is a Princeton, New Jersey based early stage biotechnology company that is developing proprietary technologies that will lead to major advances in cancer treatment. Nanocan is committed to making its disruptive innovations available to cancer patients in the U.S. and globally, including Low and Middle-Income Countries (“LMICs”), starting with countries in Africa. With novel therapeutics, Nanocan seeks to transform treatments for certain cancers.

Share article on social media or email:

COSMEDIX Continues to Expand Their Spa-Exclusive Skincare Line with the Addition of a Replenishing Gel Mask


Awaken Replenishing Gel Mask is a refreshing facial mask that helps restore balance to the complexion while helping to quench the skin with lasting hydration. COSMEDIX latest skincare addition combines the power of potent skin-loving ingredients with the gentle benefits of plant-based skincare.

COSMEDIX, a global trailblazer in the world of clean, clinical and luxurious skincare, continues to revolutionize the industry with the release of their new Replenishing Gel Mask: Awaken. Formulated with the brand’s signature, clean ingredients, this invigorating mask wraps the complexion in a cooling sensation that helps nourish, polish and balance dry skin. Awaken proudly joins the COSMEDIX Elite line as the first gel mask to be added to the spa-exclusive collection. Awaken was created in collaboration with two our COSMEDIX aestheticians, Kasey Boone, of Glow Skincare LA, and Ryan Christopher, COSMEDIX Global Director of Education.

“As a professional brand, creating an exfoliating product is a responsibility we take seriously,” says Ryan Christopher, COSMEDIX Global Director of Education. “You can’t just throw any exfoliating ingredients together and expect it to work well for everyone. That’s why we partnered with one of our leading Aestheticians, Kasey Boone, to help evaluate the performance of the formula. Kasey uses COSMEDIX exclusively in her facials and works on a wide variety of skin types so we knew she would be the perfect professional to review this product. AWAKEN is a timely addition to the ELITE category that doesn’t have any at home exfoliating products in the range. Now our spa partners can distribute this exclusive product from their treatment room to help improve most skin types and conditions.”

“I’m so excited for this collaboration with COSMEDIX,” says Kasey Boone of Glow Skincare LA, “ my favorite skincare line for the past decade in and out of the treatment room. It’s always been a dream of mine to create a medical grade product and Awaken is everything and more. This elite mask is the first of its kind. A gel formula that is great for all skin types with prebiotics to bring balance to the skin and marine algae that boosts hydration. Glow Skincare and Kasey Boone approved. This is now my go-to mask in the treatment room.

Awaken Replenishing Gel Mask is a refreshing facial mask that helps restore balance to the complexion while helping to quench the skin with lasting hydration. COSMEDIX latest skincare addition combines the power of potent skin-loving ingredients with the gentle benefits of plant-based skincare. This cooling gel mask is formulated with superfood extract and an exfoliating acid to help gently lift away dry skin, ultimately helping to reveal a smoother, more vibrant-looking complexion. With a unique Marine Algae Complex, Awaken utilizes prebiotics and amino-rich ingredients to help lock in moisture and replenish beneficial flora to the surface of the skin.

The COSMEDIX Elite collection—which features an assortment of cleanser, serum, eye treatment and moisturizer products—is excited to welcome the first gel mask to their spa-exclusive line up. Developed specifically with spas in mind, COSMEDIX Elite is made with high-level active ingredients that deliver optimal results, without the prescription. Awaken is set to kickoff the brand’s expected 2021 expansion, as COSMEDIX Elite continues to offer clean beauty to some of the world’s most renowned aestheticians, skincare professionals, plastic surgeons, dermatologists and spas. To learn more about the new Awaken Replenishing Gel Mask or any of the COSMEDIX brand’s professional skin care products, visit cosmedix.com/pro.

About COSMEDIX

COSMEDIX is a professional skincare line that is formulated with clean, potent plant-based ingredients, Nobel Prize-winning chemistry and gentle actives to deliver safe, effective results. Our commitment is to use the purest ingredients for the skin. The entire skin care line is cruelty free and free of many harsh ingredients including: parabens, benzoyl peroxide, glycolic acid, petrolatum, hydroquinone, artificial dyes and sodium lauryl sulfates.

Share article on social media or email:

Kevin Cronin Joins Protein Metrics as Vice President of Corporate Development


Kevin Cronin

Kevin brings immense experience in bioinformatics business development and in strategic planning

Protein Metrics Inc., a leading provider of biopharmaceutical and proteomics analysis software, announced today the addition Kevin Cronin, Vice President of Corporate Development, to their leadership team.

Prior to joining Protein Metrics, Kevin served as the chief commercial officer at Core Informatics for five years. During that time, he oversaw commercialization programs worldwide for the company’s innovative SaaS platform and the integration into Thermo Fishers Digital Sciences group. Before Core Informatics, Kevin was Global Vice President at the BIOVIA brand of Dassault Systèmes as well as Senior Vice President of Sales at Symyx Technologies, Inc.

“Kevin brings immense experience in bioinformatics business development and in strategic planning,” said Eric Carlson, Ph.D., President and CEO of Protein Metrics. “I’m excited to be reunited with Kevin and I look forward to having him as a valuable addition to our leadership team as we execute on our next growth phase.”

Protein Metrics supports hundreds of organizations worldwide with its Byos® desktop software for protein characterization. The Company recently launched its Byosphere™ Enterprise Platform to support collaboration across teams, projects, and geographies. Byosphere™ strengthens an organization’s biotherapeutic knowledge, and is available as an on-premise or a private-cloud deployment. The Company also has an extensive and growing portfolio of patents and intellectual property covering current products and extends into potential new application areas. (https://www.proteinmetrics.com/about-us#patents )

About Protein Metrics

Protein analysis should never be limited by software. With a clear focus on protein characterization, Protein Metrics’ vendor-neutral software allows scientists to use data generated on analytical instruments like mass spectrometers to quickly identify and report protein sequences as well as any variations from the expected form. We innovate so that biopharmaceutical companies and university research labs can achieve confident results from their analysis and reporting. With our customers, we are boldly advancing protein characterization. Protein Metrics is headquartered in Cupertino, CA at the crossroads of computing and biotechnology in the San Francisco Bay Area. For more information, visit http://www.proteinmetrics.com.

Share article on social media or email:

American Health Staffing Group Named in Staffing Industry Analysts (SIA) Largest Healthcare Staffing Firms for 2020 List


American Health Staffing Group (“AHSG”), a diversified provider of temporary healthcare staffing services and a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), announced today that it was named in the 2020 Staffing Industry Analysts (“SIA”) Largest Healthcare Staffing Firms list. This marks the third year in a row that AHSG has been named in the list.

“To be named in this list for the third year is not only a great honor for our organization, but it is also a feather in the cap to the people in our organization who have made this sustained growth possible,” Mark Smith, CEO said.

AHSG was ranked the 36th largest healthcare staffing firm in the United States. This announcement comes on the heels of AHSG also being named an SIA Fastest-Growing Staffing Firm and an SIA Best Staffing Firm to Work For, both in 2020.

According to the report, 48 staffing firms generated $50 million or more in US healthcare temporary staffing revenue in 2020. The total revenue in the healthcare staffing market exceeded $13.9 billion and the firms in the list account for 77% of the overall market.

“This team embodies the core values that we set out to put into our own culture and within the marketplace. We pride ourselves on being servant-minded and making a difference daily for our candidates, clients and community. We are excited for the years to come and the successes yet to unfold,” Smith said.

About American Health Staffing Group:

AHSG is a national and diversified healthcare staffing platform, serving 2,500+ endpoints across health systems, hospitals, and outpatient clinics in all 50 states. Headquartered in Edmond, Oklahoma and with additional offices in Michigan, Oregon, South Carolina, Colorado, and Texas, AHSG’s six divisions span across high growth and resilient segments of healthcare staffing including nursing, allied health, pharmacy, interim leadership, dialysis, and technology. AHSG is a portfolio company of BelHealth Investment Partners, LLC.

Share article on social media or email:

GeBBS Healthcare Announces Appointment of Subramanian Sankaran as the Chief Operating Officer


We are excited to have Subbu join the GeBBS team

GeBBS Healthcare Solutions, Inc. (ChrysCapital portfolio company), a leading provider of Revenue Cycle Management (RCM) Solutions for Healthcare Providers and Payers, announced today the appointment of Subramanian Sankaran as the Chief Operating Officer.

Subramanian (Subbu) brings over 27 years of industry experience to GeBBS management team. Prior to joining GeBBS, Subramanian was associated with Accenture where he led healthcare operations, F&A, supply chain for APAC region. He was instrumental in setting up and leading the global healthcare operations, insurance and BFS (Banking and Financial services) verticals at WNS Global Services along with handling operations for large payers in US market. He has also managed technical accounting and claims processes as the Global Booking leader at GE Capital International Services with special focus on property and casualty insurance and reinsurance operations. He is six sigma certified black belt.

“We are excited to have Subbu join the GeBBS team,” commented Milind Godbole, Managing Director of GeBBS Healthcare Solutions. His industry experience and illustrious track record will be invaluable to the financial success of our clients and will help maintain our operational excellence across the organization. “

“I am thrilled to join GeBBS. Leveraging the backing of ChrysCapital and GeBBS’ proven delivery Excellence framework, I am certain we can deliver meaningful solutions and innovations to our customers. I look forward to working closely with Senior leadership , Our Board, and the hugely talented employees of GeBBS to turn a new chapter of growth and value for all our stakeholders.” said Subramanian Sankaran, Chief Operating Officer of GeBBS Healthcare Solutions.

Subbu will be responsible for global service delivery, enabling RPA, business & operational excellence across the company.

About GeBBS

GeBBS Healthcare Solutions is a KLAS rated leading provider of Revenue Cycle Management (RCM) services and Risk Adjustment solutions. GeBBS’ innovative technology, combined with over 9,500-strong global workforce, helps clients improve financial performance, adhere to compliance, and enhance the patient experience. Headquartered in Los Angeles, CA, GeBBS is backed by ChrysCapital, one of the premier private equity funds based out of India. GeBBS has won numerous accolades for its medical coding outsourcing and medical billing outsourcing, including being ranked in Modern Healthcare’s Top 10 Largest RCM Firms, Black Book Market Research’s Top 20 RCM Outsourcing Services, and Inc. 5000’s fastest growing private companies in the U.S. For more information, please visit http://www.gebbs.com

For more information contact:

Tyler Cowart

310-953-4444 ext. 214/284

tyler.cowart@gebbs.com

Share article on social media or email:

New CBD-Infused Chewing Gum Promises to Blow Your mynd


The four states of mynd

Our gum delivers which is why we tell customers it will blow their mynd

Americans love chewing gum and health-conscious Americans– in surging numbers – love the health benefits of CBD, the non-intoxicating compound found in cannabis plants. Seeing an opportunity to appeal to both markets, Cannovia, a leading CBD health and wellness company, has launched its new product, mynd Gum.

“We’re excited about mynd because it gives increasingly sophisticated CBD customers exactly what they want,” said Brian Baum, Cannovia CEO. “They’re looking for ways to enjoy the benefits of CBD quickly with a product that’s portable and, most importantly, can enhance their desired states of mynd. Our gum delivers which is why we tell customers it will blow their mynd!”

The four types of mynd Gum, to be sold in two serving packs at $5/pack include “Energy”, “Focus’, “Calm” and “Recovery”.

Product Description:

________________

ENERGY – Energy drinks and pills are used by fast-paced consumers to combat low energy. Unfortunately, these products often have high levels of caffeine which means their energy surge is often followed by a crash with jitters. With its tropical fruit flavor, mynd ENERGY is different, combining the natural support of CBD and CBG, cannabinoids from hemp that supports the endocannabinoid system which regulates the body’s physiological functions so there is internal stability, along with energy-boosting caffeine and B vitamins that help the body convert nutrients for fuel, delivering an “I can do this” feeling and thanks to the CBD and CBG content, without the crash and jitters.

FOCUS – Leading busy work and personal lives with more distractions than ever, it can be difficult to concentrate on tasks in everyday life. With a great-tasting berry fruit flavor, mynd FOCUS combines the natural support of CBD and CBG, cannabinoids from hemp to stimulate the endocannabinoid system to maintain balance in the body’s physiological systems, along with the nootropic citicoline which supplies the brain with nutrition, FOCUS gum chewers can ignore distractions and focus on the most important tasks at hand.

CALM – Likely to become the more popular gum type because of the stress-inducing pandemic, mynd CALM provides the endocannabinoid system with additional cannabinoids to help regulate the body’s stress response to maintain homeostasis and a calming effect with L-Theanine, an amino acid that promotes relaxation without sleepiness. mynd CALM comes in a refreshing and relaxing mint flavor.

RECOVERY – From a night of overindulgence or the next-level workout this morning, being your best now begins with chewing gum, mynd RECOVERY. It combines CBD that stimulates the endocannabinoid system to send help where needed to balance internal systems, lessen the effects of stress, settle the unsettled and provide a boost of energy that comes from caffeine and the amino acid taurine that together promote mental alertness. RECOVERY includes Vitamin C to counteract cell-damaging free radicals that can result from alcohol and B vitamins that help the body convert nutrients for fuel.

Customer Testimonials:

__________________

In advance of launching mynd gums, customers that tested the products provided high marks, particularly because of its ability to deliver the mynd effect they sought.

“After a particularly long day, I was driving across the Colorado front range,” said Suzanne Walsh, a fan of mynd FOCUS. “As I drove, a million thoughts ran through my head. I was distracted from the drive. Then I remembered I had a sample of mynd FOCUS. I took the gum and within ten minutes – it was me and the road. I was amazed at how quickly I became laser-focused on the road.”

“I’ve never been a caffeine drinker,” said Wes Cude, a gum-smacking fan of mynd ENERGY. “But before a recent workout, I chewed a piece of mynd Energy gum and I was amazed at how quickly I felt a surge of energy. None of what I remember about caffeine followed, including the jitters. It gave me pure energy with none of the side-effects!”

Each piece of mynd gum, with concentrations of total cannabinoids ranging from 20mg to 30mg, is fast-acting, absorbs in the blood stream in less than 10 minutes. mynd is available now for online purchase at http://www.myndgum.com and will be available in selected retailers starting in 2021

Share article on social media or email: